TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Area measurement of damaged myelin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Patient Health Questionnaire (PHQ-9) total score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change on the Western Aphasia Battery - Revised, part 1 Auditory and Verbal Subtests: yields Aphasia Quotient Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change on the Communication Activities of Daily Living - 3
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change on Assessment for Living with Aphasia - 2 (Patient-Reported Outcome Measure)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Skin sodium concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change in Microcirculation parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knee Society Clinical Rating System objective knee score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change of immune cells in the blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: predictive value of changed immune cell subtype on side effect of immunotherapy
Endpoint domain: Adverse events/effects
Primary endpoint: Sensitivity of the BAT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of the BAT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of Afterload mismatch
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Turesky Modified Quigley Hein Plaque Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dental plaque coated surface areas
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility of ultrasound tip location
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cortical activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Interoceptive awareness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mindful awareness
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Unexplained cytopenia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Kidney Disease Quality of Life-36 Scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Oral microbiota structure and function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Small intestinal microbiota structure and function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Sputum microbiota structure and function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in Comfort Level
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Patient reported tolerability
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Decisional Conflict Scale Scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in risk perception
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Magnitude of antigen-specific plasmablast responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Concentration of citrullinated histone3
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Total serum bilirubin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in Direct Serum Bilirubin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in Elevated Liver Enzymes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Felt-arousal
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: number of strength exercises logged
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: liking of the intervention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Risk factors prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With DLT (Dose-limiting toxicities)
Endpoint domain: Adverse events/effects
Primary endpoint: motor performance of manual skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient-Reported Outcomes Measurement Information System (PROMIS®)-29
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Presence of post COVID-19 Symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Internal length of the nasogastric tube
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinical-biological markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Systolic and Diastolic Blood Pressure Change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Frequency of participants ingesting the required diet
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Teeth mineral composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Real World Tumor Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Average Total Body Weight Loss (TBWL%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Game performance1 (Amount of grasp initiated)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Game performance2 (Memory task accuracy)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Incidence of surgical site complications
Endpoint domain: Adverse events/effects
Primary endpoint: Behavioral Threat Expectancy Ratings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Electrodermal Activity Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CHIMES scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: WHO Oral Mucositis Grading Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clarity score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Pedicle screw loosening
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Lumbar fusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Kidney Disease and Quality of Life (KDQOL™-36)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Subchondroplasty Patient Satisfaction Survey
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: The American Orthopedic Foot and Ankle Score (AOFAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Minimal Clinically Important Improvement
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Dose of HyQvia per Kilogram of Body Weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Infusions That are Discontinued, Slowed, or Interrupted
Endpoint domain: Adverse events/effects
Primary endpoint: Total Infusion Volume
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Wingate test performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients with technically successful sMRI-guided therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Grade 3 irreversible or any Grade 4/5 neurologic toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: standardized breakfast test result
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: oral induced hyperglycemia test result
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Impact of comorbidities on disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Number of participants delivered vaginally
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Usefulness, Usability and Desirability Assessment (UUD)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Fidelity of Intervention Assessment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of participants with gestational diabetes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Percentage (%) change from baseline in Eczema Area and Severity Index (EASI) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage (%) of participants with EASI-50
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage (%) of participants with adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: American Society of Anesthesiologists physical status (ASA-PS) class
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of ≥ grade 3 Hematology related adverse event
Endpoint domain: Adverse events/effects
Primary endpoint: Mean readiness to change substance use
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence of cancer treatment adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Cumulative Number of New T1 Gadolinium-Enhancing (GdE) Lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Percent change from baseline in LDL-C levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Heart rhythm and rate monitoring measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of Participants Accrued to the Study
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percentage of Patients Who Complete Game Sessions
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Postoperative time to first request of analgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lowest CP Values [percent]
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of serious adverse events related to the intervention
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of sickle cell patients agreeing to participate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Proportion of participants accessing mindfulness videos
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Proportion of participants finding mindfulness practices enjoyable/helpful
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of patients with new neurological deficits
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change from baseline body weight at week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline body fat at week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfaction of the Intervention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Quadriceps Motor Block
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in Motor Function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in RA-associated autoantibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Frequency Adherence to Intervention
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Duration Adherence to Intervention
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: mean systemic filling pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: New Fracture
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Detection Rate of Non-Small Cell Lung Cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Absence of fracture or chipping
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Self Care
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Change in GABAergic medication usage
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Annualized change in AV Vmax
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Brain volume reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Reduction in Triglyceride Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: sensitivity and specificity of PET/CT imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Amount of Intratumoral Conventional Dendritic Cells (cDCs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Boston Carpal Tunnel Syndrome Questionnaire (BCTSQ)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in Visual Pain Scale (VAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effectiveness of LRA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Arteriovenous Fistula Flow Measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain freedom
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Freedom from most bothersome symptom
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Assisting hand assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline scores of Eating Disorder Examination Questionnaire (EDE-Q)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in FDG (18F-fluorodeoxyglucose) uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvements in PHQ-9 score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percentage of Adolescents Who Received HPV Vaccination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ViDES trial consent rate
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Participants' understanding of the ViDES study
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Participants' satisfaction with consent approach
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Anxiety Disorders Interview Schedule (ADIS-IV)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Anesthesia Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Presence of Contralateral Patent Processus Vaginalis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Responders on the Galderma Décolletage Scale (GDS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum T1 Suppression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The incidence and severity of adverse events/serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Change of EORTC QLQ-C30 at 12th week
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change of QLQ-BR23 at 12th week
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change of Mindful Attention Awareness Scale at 12th week
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Thickness change of retinal macular area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bacterial burden and composition of the respiratory microbiome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Cmax of Relma-cel
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tmax of Relma-cel
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC of Relma-cel
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in systemic inflammation - CRP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: level of asymptomatic patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Conversion rates of bilateral positive MMP-9
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Days of duration of menstruation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Thickness of the residual myometrium
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Prevalence of post-traumatic stress disorder (PTSD)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from baseline structural of gut microbiota
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change from baseline in the abundance and variability of gut microbiota
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in MRI Evaluation of Articular Cartilage Injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Total hip areal bone mineral density
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful referral and follow-up
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Victorian Institute of Sport Assessment Gluteal Questionnaire (VISA-G)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Decrease in pigmentation based on melanin index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Decrease in pigmentation based on digital imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Education programme compliance
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Feasibility of delivering the intervention online
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of local/systemic reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Number of severe cases of COVID-19
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants with Spasticity Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline to Week 5 in Spasticity NRS Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Completion of risk-stratification for penicillin allergy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stratification as low-risk with a negative immediate amoxicillin challenge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: white spot lesion color change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in standardized uptake value ratios (SUVRs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative Knee Pain Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Non-curable progression-free survival (NC-PFS)
Endpoint domain: Mortality/survival
Primary endpoint: Plasma Osmolality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of Diarrhea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Lipid Profile Level (cholesterol and triglycerides)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Quality of Life - Mental functioning
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Quality of Life - Physical functioning
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Total number of mature (MII) oocytes available for cryopreservation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Incidence of Anti-Drug Antibodies (ADA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Spectral intensity of synovial fluid components
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Combined outcome of seizure or brain injury on imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Inter-observer reproducibility of morphological quantification
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Degree of bruising post CCH injection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes